AKR1C1 and liver cancer: AKR1C1 is an aldosterone reductase with the function of catalyzing NAPDH-mediated reduction reaction, which is highly expressed in various cancers, such as liver cancer, lung cancer, and gastric cancer [20, 33, 34].